FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology. Strain of microfungus Fusarium equiseti T-14 has inhibitory activity against virus of herpes simplex type 2, influenza virus A/H1N1/California/2009 and cytostatic anticancer activity against laryngocarcinoma (Hep-2), human marrow myeloma (IM-9), human llymphadenoma (Namalva). Strain Fusarium equiseti is deposited in the Russian National Collection of Industrial Microorganisms under the registration number of VKPM F-1302 and can be used to obtain anticancer and antiviral drugs.
EFFECT: invention allows to obtain compounds exhibiting inhibitory activity against tumor cells and certain viruses that are pathogenic to human.
1 cl, 1 dwg, 4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
STRAIN OF ASIDIOMYCETE DAEDALEOPSIS CONFRAGOSA, CONTAINING PROTEINS, EXHIBITING ANTICANCER AND ANTIVIRAL ACTIVITY | 2017 |
|
RU2663111C1 |
STRAIN OF BASIDIOMYCETE INONOTUS OBLIQUUS - PRODUCER OF MELANIN PIGMENT POSSESSING ANTIVIRAL AND ANTITUMORAL ACTIVITY | 2019 |
|
RU2716590C1 |
INHIBITOR OF INFLUENZA A VIRUS REPRODUCTION BASE ON EXTRACT OF BASIDIAL FUNGUS Phallus impudicus | 2011 |
|
RU2475529C2 |
WATER-SOLUBLE PIGMENT MELANIN FROM THE BASIDIOMYCETE INONOTUS OBLIQUUS WITH ANTIVIRAL ACTIVITY | 2022 |
|
RU2800446C1 |
INHIBITOR OF INFLUENZA A VIRUS REPRODUCTION BASED ON EXTRACT OF BASIDIAL FUNGUS Laetiporus sulphureus | 2011 |
|
RU2475530C2 |
ANTIVIRAL MEDICATION BASED ON NEMATOPHAGOUS FUNGUS Duddingtonia flagrans | 2011 |
|
RU2475531C2 |
STRAIN OF BACTERIA Serratia plymuthica HAVING ANTIVIRAL ACTIVITY AGAINST INFLUENZA VIRUS OF TYPE A (VERSIONS) | 2013 |
|
RU2551316C1 |
STRAIN OF SERRATIA SPECIES BACTERIA HAVING ANTIVIRAL ACTIVITY | 2017 |
|
RU2650762C1 |
METHOD OF OBTAINING PRODUCTS WITH ANTIBACTERIAL ACTIVITY FROM THE MYCELIUM OF BASIDIOMYCETES | 2022 |
|
RU2800356C1 |
ANTIVIRAL AGENT BASED ON SERRATIA-FAMILY BACTERIA NUCLEASE | 2014 |
|
RU2580242C2 |
Authors
Dates
2018-08-15—Published
2017-11-09—Filed